期刊文献+

质粒蛋白pORF5在沙眼衣原体感染细胞中的定位及免疫原性研究(英文) 被引量:4

Immunogenicity of plasmid protein pORF5 and its localization in Chlamydia Trachomatis infected cells
下载PDF
导出
摘要 目的分析沙眼衣原体隐蔽性质粒编码的质粒蛋白pORF5在感染细胞中的定位并初步探讨免疫原性特征。方法 PCR扩增pORF5质粒蛋白编码基因,构建原核表达重组体pGEX-6p/pORF5,重组体转化大肠杆菌XL1-blue中诱导表达融合蛋白;融合蛋白经Glutathione Sepharose亲和层析纯化后免疫小鼠,制备单克隆抗体和多克隆抗体,间接免疫荧光技术及免疫印迹鉴定抗体的特异性,并分析pORF5质粒蛋白在感染细胞中的分布特征。采用ELISA方法分析pORF5质粒蛋白的免疫原性。结果 pORF5原核表达重组体成功构建,融合蛋白在大肠杆菌中可溶性表达;pORF5主要分布于宿主细胞胞浆,但也少量分布在EB、RB上;pORF5能与衣原体患者血清及鼠免疫血清发生强烈地免疫反应。结论 pORF5为衣原体分泌蛋白,并具有很强的免疫原性。 We aimed to localize the plasmid protein pORF5 in chlamydia infected cells and investigate the immunogenicity of pORF5.Firstly,the open reading frame encoding for pORF5 protein from the Chlamydia trachomatis plasmid was amplified and cloned into the pGEX-6p vector.Then the recombinant plasmid pGEX-6p/pORF5 was transformed into XL1-blue E.coli with glutathione-s-transferase(GST) to express fusion protein.After purified with Glutathione Sepharose 4B beads,the pORF5 fusion protein was used to immunize mice to make monoclonal antibody and polyclonal antibody,which were subsequently used to localize the endogenous pORF5 protein by indirect immunofluorescence assay(IFA).At the same time,ELISA was used to determine the immunogenicity of pORF5 plasmid protein through recognizing the pool sera of patients infected with Chlamydia trachomatis and the pool sera of mice immunized with pORF5 fusion protein.pORF5 was dominantly expressed in the cytosol of the Chlamydia-infected cells,and also appeared in the RBs and EBs in small quantity;pORF5 protein could strongly reacted with antiserum.In conclusion,pORF5 plasmid protein is identified as a secreted protein with good immunogenicity,which lay the foundation for studying the biological activities and the development of the Chlamydia trachomatis vaccine against this pathogen.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第2期93-97,104,共6页 Immunological Journal
基金 国家自然科学基金(30970165) 湖南省自然科学基金重点项目(09JJ3059)
关键词 沙眼衣原体 质粒 分泌蛋白 pORF5 免疫原性 Chlamydia trachomatis Plasmid Secreted protein pORF5 Immunogenicity
  • 相关文献

参考文献14

  • 1O'Connell CM, Ingalls RR, Andrews CW, et al. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease [J]. J |mmunol, 2007,179 (64):4027-4034.
  • 2Pickett MA, Everson JS, Pead PJ, et al. The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents [J]. Microbiology, 2005, 151: 893-903.
  • 3Dong F, Zhong Y, Arulanandam B, et al. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species [J]. Infect Immun, 2005, 73:1868-1872.
  • 4Sharma J, Dong F, Pirbhai M, et al. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis[J]. Infect Immun, 2005, 73: 4414-4419.
  • 5Xiao Y, Zhong Y, Su H, et al. NF-kappa B activation is not required for Chlamydia trachomafis inhibition of host epithe- lial cell apoptosis[J]. J Immunol, 2005, 174:1701-1708.
  • 6Smith JS, Munoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Phihppines [J]. J Infect Dis, 2002, 185(3) : 324-331.
  • 7Coker PR, Smith KL Fellows PF, et al. Bacillus anthracis virulence in guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality[J]. J Chn Microbiol, 2003, 41:1212-1218.
  • 8Sharma J, Zhong Y, Dong F, et al. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins[J]. Infect Immun, 2006, 74(3):1490-1499.
  • 9Sharma J, Bosnic AM, Piper JM, et al. Human antibody responses to a Chlamydia-secreted protease factor [J]. Infect Immun, 2004, 72( 12):7164-7171.
  • 10Chaganty BK, Murthy AK, Evani S J, et al. Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge [J]. Vaccine, 2010, 28 (11)2323-2329.

同被引文献27

  • 1程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:87
  • 2陈超群,吴移谋,李忠玉,尹卫国,谭立志.沙眼衣原体外膜蛋白2重组蛋白的表达纯化和免疫性鉴定[J].中华检验医学杂志,2005,28(7):697-699. 被引量:2
  • 3Burton MJ,Adegbola RA,Kinteh F,et al.Bacterial infectionand trachoma in the gambia:a case control study[J].InvestOphthalmol Vis Sci,2007,48(10):4440-4444.
  • 4Centers for Disease Control and Prevention CDC.Chlamydiascreening among sexually active young female enrollees ofhealth plans--United States,2000-2007[J].MMWR MorbMortal Wkly Rep,2009,58(14):362-365.
  • 5Eley A,Hosseinzadeh S,Hakimi H,et al.Apoptosis ofejaculated human sperm is induced by co-incubation withChlamydia trachomatis lipopolysaccharide[J].Hum Reprod,2005,20(9):2601-2607.
  • 6Chen D,Lei L,Flores R,et al.Autoprocessing andself-activation of the secreted protease CPAF inChlamydia-infected cells[J].Microb Pathog,2010,49(4):164-173.
  • 7Wang J,Zhang Y,Lu C,et al.A genome-wide profiling ofthe humoral immune response to Chlamydia trachomatisinfection reveals vaccine candidate antigens expressed inhumans[J].J Immunol,2010,185(3):1670-1680.
  • 8Hubacher D,Lara Ricalde R,Taylor DJ,et al.Use of copperintrauterine devices and the risk of tubal infertility amongnulligravid women[J].N Engl J Med,2001,345(8):561-567.
  • 9Wilson DP,Whittum Hudson JA,Timms P,et al.Kinematicsof intracellular chlamydiae provide evidence forcontact-dependent development[J].J Bacteriol,2009,191(18):5734-5742.
  • 10Zhong G.Chlamydia trachomatis secretion of proteases formanipulating host signaling pathways[J].Front Microbiol,2011,2(14):1-5.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部